Mendel Haag

Mendel Haag has extensive experience in epidemiology and outcomes research, with a career spanning multiple prominent organizations in the pharmaceutical and vaccine sectors. At Pfizer bv, roles include Outcomes Research Representative and Outcomes Research Associate, contributing to vital research initiatives. At Novartis, Mendel held positions as Principal Epidemiologist and Senior Epidemiologist, focusing on meningitis and influenza, and later served as an Epidemiologist and Head of Epidemiology at Novartis Influenza Vaccines. A strategic leader at Seqirus from 2015 to 2021, responsibilities included designing global epidemiological research strategies for vaccine products. Currently, Mendel serves as Sr. Director at CSL Seqirus, overseeing the Center of Outcomes Research & Epidemiology. Academic credentials include a PhD and MSc in Clinical Epidemiology from Erasmus University Rotterdam, alongside a PharmD from Utrecht University, and fields of study in neuroepidemiology and pharmacoepidemiology.